{"id":4247,"date":"2016-11-15T22:20:00","date_gmt":"2016-11-16T03:20:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/ataga-nejm\/"},"modified":"2023-06-06T17:06:57","modified_gmt":"2023-06-06T21:06:57","slug":"ataga-nejm","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/","title":{"rendered":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain"},"content":{"rendered":"<p><!-- description --><\/p>\n<figure class=\"thumbnail wp-caption alignright\" style=\"width: 235px\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\" alt=\"Kenneth Ataga, MBBS\" width=\"225\" height=\"150\" \/><figcaption class=\"caption wp-caption-text\">Kenneth Ataga, MBBS, principal investigator of the SUSTAIN trial and director of the Comprehensive Sickle Cell Program in the University of North Carolina School of Medicine.<\/figcaption><\/figure>\n<p>Results from an international, multicenter phase 2 clinical trial led by Dr. Kenneth Ataga were published online by the New England Journal of Medicine on December 3 and were presented December 4 at the annual meeting of the American Society of Hematology in San Diego. The trial found that an investigational compound called SeIG1 dramatically reduces sickle cell pain crises.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><!-- description --> <\/p>\n<p class='lead'>Results from an international, multicenter phase 2 clinical trial led by Dr. Ataga were published online by the New England Journal of Medicine on December 3 and were presented December 4 at the annual meeting of the American Society of Hematology in San Diego. The trial found that an investigational compound called SeIG1 dramatically reduces sickle cell pain crises.<\/p>\n","protected":false},"author":18672,"featured_media":4248,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[69],"class_list":["post-4247","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-69","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Results from an international, multicenter phase 2 clinical trial led by Dr. Ataga were published online by the New England Journal of Medicine on December 3 and were presented December 4 at the annual meeting of the American Society of Hematology in San Diego. The trial found that an investigational compound called SeIG1 dramatically reduces sickle cell pain crises.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-16T03:20:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T21:06:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"266\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kristen Hendrickson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kristen Hendrickson\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\"},\"author\":{\"name\":\"Kristen Hendrickson\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181\"},\"headline\":\"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain\",\"datePublished\":\"2016-11-16T03:20:00+00:00\",\"dateModified\":\"2023-06-06T21:06:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\"},\"wordCount\":103,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\",\"keywords\":[\"2016\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\",\"name\":\"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\",\"datePublished\":\"2016-11-16T03:20:00+00:00\",\"dateModified\":\"2023-06-06T21:06:57+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg\",\"width\":266,\"height\":400,\"caption\":\"Kenneth Ataga, MBBS, principal investigator of the SUSTAIN trial and director of the Comprehensive Sickle Cell Program in the University of North Carolina School of Medicine.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181\",\"name\":\"Kristen Hendrickson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/08109d09683c52bea3641a343e82d97089894d2bd8c0ab3d619ab909785b5288?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/08109d09683c52bea3641a343e82d97089894d2bd8c0ab3d619ab909785b5288?s=96&d=mm&r=g\",\"caption\":\"Kristen Hendrickson\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/berit\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine","og_description":"Results from an international, multicenter phase 2 clinical trial led by Dr. Ataga were published online by the New England Journal of Medicine on December 3 and were presented December 4 at the annual meeting of the American Society of Hematology in San Diego. The trial found that an investigational compound called SeIG1 dramatically reduces sickle cell pain crises.","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2016-11-16T03:20:00+00:00","article_modified_time":"2023-06-06T21:06:57+00:00","og_image":[{"width":266,"height":400,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","type":"image\/jpeg"}],"author":"Kristen Hendrickson","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kristen Hendrickson"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/"},"author":{"name":"Kristen Hendrickson","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181"},"headline":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain","datePublished":"2016-11-16T03:20:00+00:00","dateModified":"2023-06-06T21:06:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/"},"wordCount":103,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","keywords":["2016"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/","name":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","datePublished":"2016-11-16T03:20:00+00:00","dateModified":"2023-06-06T21:06:57+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","width":266,"height":400,"caption":"Kenneth Ataga, MBBS, principal investigator of the SUSTAIN trial and director of the Comprehensive Sickle Cell Program in the University of North Carolina School of Medicine."},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/ataga-nejm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Dr. Kenneth Ataga leads clinical trial for drug that dramatically reduces sickle cell pain"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/cc05c93539ac00f6bfa3647b410f7181","name":"Kristen Hendrickson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/08109d09683c52bea3641a343e82d97089894d2bd8c0ab3d619ab909785b5288?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08109d09683c52bea3641a343e82d97089894d2bd8c0ab3d619ab909785b5288?s=96&d=mm&r=g","caption":"Kristen Hendrickson"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/berit\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2-200x300.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/ataga-nejm-image2-150x150.jpeg","featured_image_alt":"Kenneth Ataga, MBBS, principal investigator of the SUSTAIN trial and director of the Comprehensive Sickle Cell Program in the University of North Carolina School of Medicine.","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"}],"tag_details":[{"name":"2016","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2016\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/4247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/18672"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=4247"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/4247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/4248"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=4247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=4247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=4247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}